XML 37 R25.htm IDEA: XBRL DOCUMENT v3.4.0.3
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Apr. 30, 2016
STOCK-BASED COMPENSATION  
Summary of Activity under Option and Stock Plans

 

 

 

Shares

 

Exercise
Price

 

Remaining
Term (years)

 

Fair Value

 

Outstanding, February 1, 2016

 

1,064

 

$

26.38

 

6.36

 

$

6.91

 

Granted

 

75

 

$

33.85

 

 

 

 

 

Exercised

 

(22

)

$

18.80

 

 

 

 

 

Outstanding, April 30, 2016

 

1,117

 

$

27.03

 

6.92

 

$

7.08

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable, April 30, 2016

 

842

 

$

24.36

 

6.43

 

$

6.41

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares

 

Exercise
Price

 

Remaining
Term (years)

 

Fair Value

 

Outstanding, February 1, 2015

 

876

 

$

22.34

 

7.08

 

$

6.01

 

Granted

 

100

 

$

32.68

 

 

 

 

 

Exercised

 

(38

)

$

11.48

 

 

 

 

 

Forfeited

 

(6

)

$

17.33

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding, April 30, 2015

 

932

 

$

23.92

 

7.32

 

$

6.38

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable, April 30, 2015

 

707

 

$

21.01

 

6.82

 

$

5.72

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Summary of Change in Number of Non-Vested Options to Purchase Shares of Common Stock

 

 

 

Shares

 

Fair Value

 

Nonvested, February 1, 2016

 

300

 

$

8.97

 

Granted

 

75

 

$

9.01

 

Vested

 

(100

)

$

8.55

 

 

 

 

 

 

 

 

Nonvested, April 30, 2016

 

275

 

$

9.13

 

 

 

 

 

 

 

 

 

 

 

Shares

 

Fair Value

 

Nonvested, February 1, 2015

 

306

 

$

7.14

 

Granted

 

100

 

$

8.55

 

Vested

 

(181

)

$

6.28

 

 

 

 

 

 

 

 

Nonvested, April 30, 2015

 

225

 

$

8.45

 

 

 

 

 

 

 

 

 

Summary of Assumptions Used to Estimate Fair Value of Stock Options Granted

 

 

 

Three Months Ended April 30,

 

 

 

2016

 

2015

 

Dividend yield

 

2.07 

%

2.14 

%

Expected volatility

 

34.08 

%

34.63 

%

Risk-free interest rate

 

1.02 

%

1.40 

%

Expected life in years

 

5.50 

 

5.13